EWA
ANRO icon

EverSource Wealth Advisors’s Alto Neuroscience ANRO Stock Holding History

EverSource Wealth Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Sell
560
-68
-11% -$1.57K ﹤0.01% 2656
2026
Q1 		$14.1K Sell
628
-33
-5% -$612 ﹤0.01% 2731
2025
Q4 		$11.8K Sell
661
-64
-9% -$806 ﹤0.01% 2720
2025
Q3 		$2.92K Buy
725
+101
+16% +$335 ﹤0.01% 3387
2025
Q2 		$1.37K Buy
624
+620
+15,500% +$1.48K ﹤0.01% 3635
2025
Q1 		$9 Buy
+4
New +$14 ﹤0.01% 3992

Other funds holding ANRO

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EverSource Wealth Advisors's ANRO Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Alto Neuroscience (ANRO) stake by 11% in Q2 2026, selling an estimated $1.57K and leaving 560 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

EverSource Wealth Advisors first reported a position in ANRO in Q1 2025 and has held it in 6 quarters since. 21 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • EverSource Wealth Advisors held 560 shares of Alto Neuroscience worth $14.8K as of Q2 2026.
  • EverSource Wealth Advisors sold 68 Alto Neuroscience shares in Q2 2026, an estimated $1.57K.
  • Alto Neuroscience made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2656 holding.
  • EverSource Wealth Advisors first reported a position in Alto Neuroscience in Q1 2025 and has held it in 6 quarters since.
  • 21 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.